Additional lots of the widely-used diabetes drug, metformin hydrochloride, have been recalled after they were found to contain unacceptably high levels of a cancer-causing contaminant. Marksans Pharma Limited, India has voluntarily expanded its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, &...
EXPANDED RECALL OF POPULAR DIABETES DRUG DUE TO HIGH LEVELS OF CANCER-CAUSING AGENT
